Consilient Health
Maeve Devery is an experienced HR professional who has worked in various roles across different companies. Maeve has a background in HR administration, training, recruitment, and management. Maeve is skilled in talent acquisition, performance management, employee engagement, and organizational development. Maeve holds a BA in Human Resource Management Strategy & Practice and has certifications in training, personal training, and supervisory skills. Currently, Maeve is working as an HR People Partner at Consilient Health, where Maeve collaborates with leaders to provide tailored HR solutions.
This person is not in any teams
Consilient Health
Consilient Health is a pharmaceutical company with a rich heritage of commercialising medicines in areas including women’s health, urology and endocrinology. Established in 2005, Consilient Health is headquartered in Ireland with offices in the UK and Sweden (for the Nordic region) We have formed strong partnerships in Benelux and Spain and continue to expand our geographic footprint in Europe. As an independent, privately-held and profitable business with a strong balance sheet, we can make decisions quickly and are able to invest in long-term collaborations and partnerships to expand our portfolio of products and to support our partners’ objectives. Our goal is to address patients’ and healthcare professionals’ unmet needs with medicines that are differentiated and we are actively seeking to in-license late stage developments or marketed products. We do not undertake research and development and are not a manufacturer. Consilient Health deliver everything from regulatory affairs through to market access, supply chain, distribution, medical affairs, marketing and sales all underpinned by quality and compliance. Our focus is on driving value in our partners’ brands, maximizing their commercial potential, enabling them to expand their geographical footprint and providing access for patients. For more information please visit www.consilienthealth.com CORP-CH-204(2) Date of preparation July 2022